ArticleBMC bioinformatics2025
DeepSEA: an alignment-free explainable approach to annotate antimicrobial resistance proteins.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence for early detection and risk prediction of antimicrobial resistance in aquatic ecosystems.npj antimicrobials and resistance · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Antimicrobial resistance (AMR) is one of the most concerning modern threats as it places a greater burden on health systems than HIV and malaria combined. Current surveillance strategies for tracking antimicrobial resistance (AMR) rely on genomic comparisons and depend on sequence alignment with strict similarity cutoffs of greater than 95%. Therefore, these methods have high false-negative error rates due to a lack of reference sequences with a representative coverage of AMR protein diversity. Deep learning has been used as an alternative to sequence alignment, as artificial neural networks can extract abstract features from data, thereby limiting the need for sequence comparisons. Here, a convolutional neural network (CNN) was trained to differentiate between antimicrobial resistance proteins and non-resistance proteins, and to annotate them in nine resistance classes. Our model demonstrated higher recall values (> 0.9) than the alignment-based approach for all protein classes tested. Additionally, our CNN architecture allowed us to investigate internal states and explain the model classification regarding protein domain feature importance related to antimicrobial molecule inactivation. Finally, we built an open-source bioinformatic tool ( https://github.com/computational-chemical-biology/DeepSEA-project ) that can be used to annotate antimicrobial resistance proteins and provide information on protein domains without sequence alignment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.